He Junli 4/A
4/A · Biostage, Inc. · Filed Jul 10, 2023
Insider Transaction Report
Form 4/AAmended
Biostage, Inc.BSTG
He Junli
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2023-04-10+267,616→ 267,616 totalExercise: $6.08Exp: 2033-04-10→ Common Stock, par value $0.01 per share (267,616 underlying)
Footnotes (1)
- [F1]On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.